13. Multiple sclerosis/Neuromyelitis optica Clinical trials / Disease details
Clinical trials : 3,342 / Drugs : 2,355 - (DrugBank : 406) / Drug target genes : 269 - Drug target pathways : 241
| No. | TrialID | Date_ enrollment | Date_ registration | Public_title | Scientific_title | Condition | Intervention | Primary_ sponsor | Secondary_ sponsor | Recruitment_ Status | Inclusion_ agemin | Inclusion_ agemax | Inclusion_ gender | Target_ size | Phase | Countries |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | EUCTR2006-004318-42-NL (EUCTR) | 12/12/2006 | 03/08/2006 | Influence on brain perfusion and metabolism through pharmacologic agents | Influence on brain perfusion and metabolism through pharmacologic agents | Multiple Sclerosis MedDRA version: 8.1;Level: PT;Classification code 10028245;Term: Multiple sclerosis | Trade Name: Prepulsid Trade Name: Spiropent | Department of Neurology UMCG | NULL | Authorised-recruitment may be ongoing or finished | Female: yes Male: yes | Netherlands |